$BSEM News

BioStem Technologies, Inc. (BSEM) Q1 2026 Earnings Call Transcript

BioStem Technologies, Inc. (BSEM) Q4 2025 Earnings Call Transcript

BioStem Technologies, Inc. 2025 Q4 - Results - Earnings Call Presentation

BioStem Technologies, Inc. (BSEM) M&A Call Transcript

Assessing BioStem Technologies (OTCPK:BSEM) Valuation After Recent Share Price Strength

Is It Time To Reassess BioStem Technologies (OTCPK:BSEM) After Its Recent Share Price Swings

BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes

BioStem Technologies Products Placed on “12-Month Status Quo Period” List in Update to CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes

BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference

BioStem Technologies Expands Product Access in Medicaid

BioStem Technologies Inc (BSEM) Q3 2025 Earnings Call Highlights: Strong Demand and Strategic ...

BioStem Technologies Reports Third Quarter 2025 Financial Results

BioStem Technologies Announces Filing of Restated Financial Statements

BioStem Technologies, Inc. (BSEM) Q3 2025 Earnings Call Transcript

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers

BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025

BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program

BioStem Technologies, Inc. (BSEM) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)